U.S. Oncology and Baylor Health Care System are teaming up on an ambitious new joint venture that will explore the development of new, personalized cancer therapies targeted at specific genes. The Dallas Business Journal dug up a rough outline of their plans to hire up to 900 people in Lewisville, TX who will earn an annual payroll of $67 million.
The Business Journal didn't reach any of the principals in the deal, but it says that the company has leased a 172,000-square-foot facility and will have 214 people on staff by the end of this year. The company plans to focus on pharmacogenomics--the interplay between genetics and new drugs. And they're looking for "cytogenetics, medical technologists, laboratory managers, a global logistics manager and a directory of quality assurance and regulatory affairs."
- here's the story from the Dallas Business Journal